BSEBoard Meeting10 Aug 2026 · 10 Aug 2026, 04:06 pm

Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the following businesses: 1. ....

Natraj Proteins Ltd · 530119

✦ AI SummaryResults

Natraj Proteins Ltd has scheduled a Board Meeting on 13th August 2026 to consider and approve the unaudited financial results for the quarter ended 30th June 2026, along with other routine businesses.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natraj Proteins Ltd - 530119 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 30Th June, 2026

Attachments (1)

📄

53c0c9cb-c760-4974-b3c7-73cba7ef5a34.pdf

pdf

Download →
View document text
NPL/SE/2026-27 Date: 10th August, 2026 Online Filing at: www.listing.bseindia.com The General Manager DCS-CRD BSE Limited Dalal Street, Fort MUMBAI – 400001 BSE CODE: 530119 Subject: Corporate Announcement under regulation 29(1)(a) of SEBI (LODR) Regulations, 2015 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 as may be applicable, regarding intimation of holding the 03/2026-27 Board Meeting for consideration and approval of the Un-Audited Financial Results for the Quarter ended 30th June, 2026. Dear Sir, Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 as may be applicable, we are pleased to inform that 03/2026-27 Meeting of the Board of directors of the Company is scheduled to be held on Thursday the 13th day of August, 2026 at the Registered office of the company situated at Nagpur Kalan, Ordinance Factory Road, Itarsi (M.P.) 461111 to consider and approve the following businesses along with other routine businesses: 1. To consider and approve the Un-Audited Financial Results of the Company for the Quarter ended 30th June, 2026. 2. To consider and approve the Limited Review Report by the Statutory Auditors for the Un- Audited Financial Results of the Company for the Quarter ended 30th June, 2026. 3. Other Routine Business Items. Further, in accordance with the Company’s Code for Prevention of Insider Trading, the Trading Window for dealing in the Company’s securities is already closed and will open 48 hours after the financial results for the Quarter ended June 30, 2026, are declared to the Stock Exchanges. You are requested to please take on record our above said information for your reference and disseminate it on the website of the BSE. Thanking you. Yours faithfully, For, NATRAJ PROTEINS LIMITED HARSHITA KIRKIRE COMPANY SECRETARY & COMPLIANCE OFFICER